References
- Hofnagle J H, Mullen K D, Jones D B, Rustgi V, Di Bisceglie A, Peters M, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: a preliminary report. N Engl J Med 1986; 315: 1575–8
- Davis G L, Balart L A, Schiff E R, Lindsay K, Bodenheimer HC, Jr, Perillo R P, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter, randomized, controlled trial. N Engl J Med 1989; 321: 1501–6
- Di Bisceglie A M, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al. Recombinant interferon alfa therapy for chronic hepatitis C a randomized, double blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506–10
- Sherlock S. Viral hepatitis C. Curr Opinion Gastroenterol 1993; 9: 341–8
- Albert A., Chemello L, Bonetti P, Casarin C, Diodati G, Cavalletto L, et al. Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. J Hepatol 1993; 17: S123–6, Suppl 3
- Camps J, Crisostomo S, Garcia-Granero M, Reizu-Boj J I, Civeira M P, Prieto J. Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables. Gut 1993; 34: 1714–7
- Davis G L, Lindsay K, Albrecth J, Bodenheimer H C, Balart L A, Perillo R P, et al. Predictor of response to recombinant alpha interferon in patients with chronic hepatitis C [abstract]. Hepatology 1990; 12: 905
- Puoti M, Zonaro R, Ravaggi A, Marim M G, Castelnuovo F, Cariani EI. Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection. Hepatology 1992; 16: 877–81
- Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-a. Hepatology 1992; 15: 37–41
- Shindo M, Di Bisceglie A M, Cheung L, Shik J W, Cristiano K, Feinstone S M, et al. Decrease in serum hepatitis C virus RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991; 115: 700–4
- Shindo M, Di Bisceglie A M, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with a-interferon. Hepatology 1992; 15: 1013–26
- Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 24: 359–62
- Kuo G, Choo Q L, Alter H J, Gitnik G L, Redeker A G, Purcell R H, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4
- Tine F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, non-B hepatitis: a meta-analysis of randomized clinical trails. J Hepatol 1991; 13: 192–9
- Reichard O, Foberg U, Fryden A, Mattsson L, Norkrans G, Sonnerborg A, et al. High sustained response rate and clearence of viremia in chronic hepatitis C after treatment with interferon-α2b for 60 weeks. Hepatology 1994; 19: 280–5
- Christian K, Di Bisceglie A M, Hoofnagle J H, Feinstone SM. Hepatitis C viral RNA in serum of patients with chronic non-A non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology 1991; 14: 51–5
- Muller H M, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993; 74: 669–76
- Lau Y N, Mizokami M, Ohno T, Diamond D A, Kniffen J, Davis GL. Discrepancy between biochemical and virological responses to interferon-a in chronic hepatitis C. Lancet 1993; 342: 1208–9
- Chemello L, Alberti A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994; 330: 143
- Gerolami V, Halfon P, Bourliere M, Khiri H, Reynier P, Garneier PP. Hepatitis C virus genotypes in chronic hepatitis and response to interferon-α therapy. J Infect Dis 1993; 168: 1328–9
- Nordøy I, Schrumpf E, Elgjo K, Flesland Ø, Andersen Glende J, Ørjasôter H, et al. Liver disease in anti-hepatitis C virus-positive Norwegian blood donors. Scand J Gastroenterol 1994; 29: 77–81
- Bjøro K, Frøland S S, Zhibing Y, Samdal H H, Haaland T. Hepatitis C infection in primary hypogammaglobulinemia following intravenous substitution with contaminated immune globulin. N Engl J Med 1994; 331: 1607–11